NRXCF - NeutriSci International Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1085
+0.0028 (+2.65%)
At close: 3:42PM EDT
Stock chart is not supported by your current browser
Previous Close0.1057
Open0.1107
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0955 - 0.1107
52 Week Range0.0520 - 0.2705
Volume126,300
Avg. Volume12,976
Market Cap11.614M
Beta4.22
PE Ratio (TTM)N/A
EPS (TTM)-0.0170
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago

    Nutritional High and NeutriSci International to Launch Cannabis-Infused Tablets July 11th

    NeutriSci International Inc. ("NeutriSci") (NU.V) (NRXCF) (1N9.F) the innovator and pioneer behind neuenergy® is pleased to provide an update on its previously announced partnership with Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE:EAT) (SPLIF) (2NU.F) (see press release dated May 30th, 2018). As of July 11th, 2018, NeutriSci and Nutritional High will commence the production process of its newly developed chewable, sublingual THC product (“Tablets”) for sale and distribution in the state of California. The Tablets will be produced at the Company’s Pasa Verde manufacturing facility, located in Sacramento, California.

  • GlobeNewswire2 months ago

    Nutritional High and NeutriSci to Launch Cannabis-Infused Nu Energy Tablets July 11th

    Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE:EAT) (SPLIF) (2NU.F) is pleased to provide an update on its previously announced partnership with NeutriSci International Inc. ("NeutriSci") (NU.V) (NRXCF) (1N9.F) (see press release dated May 30th, 2018). As of July 11th, 2018, NeutriSci and Nutritional High will commence the production process of its newly developed chewable, sublingual THC product (“Nu Energy Tablets”) for sale and distribution in the state of California. The Nu Energy Tablets will be produced at the Company’s Pasa Verde manufacturing facility, located in Sacramento, California.

  • Newsfile7 months ago

    Neutrisci Files Patent Application

    Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci")  the innovator and pioneer behind neuenergy®, is pleased to announce the filing of a new U.S. provisional patent application (United States Provisional Patent No. 62/628,735; Compositions Comprising Co-crystals of Stilbenoids and Cannabinoids) relating to compositions comprising pterostilbene and other stilbenoids in formulations which improve the dissolution rate and bioavailability of cannabinoid compounds.Cannabinoids ...

  • Newsfile7 months ago

    Neutrisci and Lexaria Bioscience Enter Global Licensing Agreement

    Vancouver, British Columbia--(Newsfile Corp. - February 26, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci") and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) ("Lexaria") are pleased to announce that they have revised their joint venture agreement such that NeutriSci now owns 100% of Ambarii Trade Corporation ("Ambarii"), and Lexaria has granted to NeutriSci, an Intellectual Property License and Supply Agreement (the "License Agreement") for the manufacturing and sale of CBD ...

  • ACCESSWIRE7 months ago

    Lexaria and Neutrisci Enter Global Licensing Agreement

    KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / February 26, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces ...

  • Marketwired8 months ago

    NeutriSci Announces Major Sponsorship With Tennis Star Genie Bouchard

    NeutriSci International Inc. , the innovator and pioneer behind neuenergy®, is pleased to announce a one-year sponsorship deal with Canadian and International tennis...

  • Newsfile8 months ago

    Neutrisci Announces a Major R&D MOU with Scientus Pharma to Develop a Medical Cannabinoid Retail Product

    Vancouver, British Columbia--(Newsfile Corp. - January 8, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci"), the innovator and pioneer behind neuenergy®, is pleased to announce it has entered into a major R&D Memorandum of Understanding with Scientus Pharma Inc. ("Scientus Pharma"). Under the terms of the MOU, both companies have agreed to share their technologies to develop, test, produce, and distribute a medical cannabinoid product for existing ...

  • Marketwired11 months ago

    NeutriSci Announces Pending Approval From Japanese Government for Distribution of CBD Products Through Naturally Splendid

    NeutriSci International Inc. , the innovator and pioneer behind neuenergy®, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation...